GHK-Cu peptide hair growth claims: what the science actually shows
Quick answer
The video promotes a compounded peptide product called EFX Regen for hair restoration, claiming it reverses hair loss at the cellular level and produces results comparable to teenage hair growth. Peptides like GHK-Cu have preliminary in vitro and animal-model evidence for follicle stimulation, but no published human clinical trials support the sustained reversal claims made here for any branded peptide product. Patients concerned about hair loss should consult a licensed clinician to evaluate the underlying cause, whether androgenetic, inflammatory, or nutritional, before pursuing any unproven supplement regimen.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @hair.rescue7 actually say?
The creator made three distinct claims worth separating out. First, that minoxidil and transplants both fail because they don't stop ongoing hair loss. Second, that "hair growth peptides" are "by far the best option for hair restoration in 2025." Third, that a specific product called EFX Regen produces results so dramatic that a friend "went viral on Twitter" after five months of use. The framing here is classic before-and-after influencer marketing dressed up in clinical-sounding language. Phrases like "actual reversal of hair loss at the cellular level" and hair "growing like it did when you were a teenager" are doing a lot of work without any referenced data behind them. The creator also says "I don't usually recommend products directly" immediately before recommending a product directly. That disclaimer is not a disclaimer. It's a rhetorical setup.
Does the science back this up?
Partially, but nowhere near as far as the video implies. The peptide with the strongest hair-related evidence is GHK-Cu (copper tripeptide-1), and even that evidence is modest. Not miraculous.
A 2018 study by Gorouhi and Maibach in International Journal of Trichology found GHK-Cu showed some promise in stimulating follicle activity and reducing inflammation around the follicle, but the evidence was graded as preliminary. A 2019 in vitro study by Choi et al. in Biomolecules found GHK-Cu promoted hair follicle cell proliferation in lab conditions. In vitro results and actual scalp results are not the same thing. Other peptides in the "hairgrowthpeptides" category, like BPC-157 and TB-500, have animal-model evidence for tissue repair and angiogenesis, which theoretically could support follicle health, but human hair loss trials simply do not exist yet for these compounds. Claiming these peptides produce teenage-era regrowth that "actually stays that way" is not supported by any published clinical trial.
What did they get wrong (or right)?
They got one thing basically right: minoxidil does not prevent the underlying hormonal and genetic processes driving androgenetic alopecia. That is accurate. Minoxidil extends the anagen (growth) phase and increases blood flow to follicles, but it does not block DHT or address follicle miniaturization at its source. Finasteride does that, and the creator never mentions it, which is a notable omission in any conversation about "preventing further loss."
What they got badly wrong: the claim of "actual reversal of hair loss at the cellular level" applied to a branded product is not a scientific statement. It is a marketing statement. No peer-reviewed human trial has demonstrated that any peptide product reverses androgenetic alopecia in a sustained, measurable way comparable to what the creator describes. The viral Twitter transformation is anecdotal evidence. One person's five-month photo sequence, however dramatic, is not a clinical outcome. Lighting, camera angle, hair styling, and product buildup all affect how hair appears in photos. This is not evidence that EFX Regen "flat out works."
What should you actually know?
If you are losing hair, the evidence hierarchy looks nothing like what this video presents. Finasteride (for androgenetic alopecia in appropriate candidates) has decades of randomized controlled trial data. Minoxidil has strong evidence for slowing loss and modest evidence for regrowth. Low-level laser therapy has some supportive data. Peptides like GHK-Cu are legitimately interesting to researchers, but they are not yet proven treatments for hair loss in humans at any standardized dose or formulation.
Compounded peptide products marketed as hair restoration tools are not FDA-approved for that use. The FDA does not evaluate the safety or efficacy of compounded formulations the same way it evaluates approved drugs. If you are curious about peptide-based approaches to hair health, that is a reasonable thing to discuss with a licensed clinician who can review your full picture, not a TikTok video promoting a specific product. A one-size-fits-all supplement is not a substitute for understanding why your hair is falling out in the first place.
- GHK-Cu has preliminary research support for follicle stimulation, not proven reversal of hair loss.
- No published human trial confirms EFX Regen or any comparable product reverses androgenetic alopecia.
- Viral social media transformations are not clinical evidence.
- Finasteride and minoxidil have far more evidence than any peptide product currently on the market for hair loss.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
GHK-Cu (Copper Peptide) access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GHK-Cu peptide hair growth claims: what the science actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this ghk-cu video claims cluster
Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.
Claim verdict
The useful answer behind this video
Claim being checked
The video promotes a compounded peptide product called EFX Regen for hair restoration, claiming it reverses hair loss at the cellular level and produces results comparable to teenage hair growth.
FormBlends verdict
The video promotes a compounded peptide product called EFX Regen for hair restoration, claiming it reverses hair loss at the cellular level and produces results comparable to teenage hair growth. Peptides like GHK-Cu have preliminary in vitro and animal-model evidence for follicle stimulation, but no published human clinical trials support the sustained reversal claims made here for any branded peptide product. Patients concerned about hair loss should consult a licensed clinician to evaluate the underlying cause, whether androgenetic, inflammatory, or nutritional, before pursuing any unproven supplement regimen.
Patient-safe next step
Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video promotes a compounded peptide product called EFX Regen for hair restoration, claiming it reverses hair loss at the cellular level and produces results comparable to teenage hair growth. Peptides like GHK-Cu have preliminary in vitro and animal-model evidence for follicle stimulation, but no published human clinical trials support the sustained reversal claims made here for any branded peptide product. Patients concerned about hair loss should consult a licensed clinician to evaluate the underlying cause, whether androgenetic, inflammatory, or nutritional, before pursuing any unproven supplement regimen.
- GHK-Cu, the peptide most studied for hair effects, showed follicle-stimulating potential in a 2019 Choi et al. study in Biomolecules, but only in lab cell cultures, not in human scalp trials.
- Finasteride has over 20 years of randomized controlled trial data for androgenetic alopecia. No peptide product currently matches that evidence level in humans.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.
Review GHK-Cu (Copper Peptide)What You'll Learn
- GHK-Cu, the peptide most studied for hair effects, showed follicle-stimulating potential in a 2019 Choi et al. study in Biomolecules, but only in lab cell cultures, not in human scalp trials.
- Finasteride has over 20 years of randomized controlled trial data for androgenetic alopecia. No peptide product currently matches that evidence level in humans.
- The FDA has not approved any compounded peptide formulation for hair loss treatment, and compounded products are not evaluated for efficacy the same way approved drugs are.
- One viral Twitter photo sequence is anecdotal evidence. Lighting, styling, and camera angle all affect how hair appears in photos, and none of these factors were controlled for.
- Minoxidil's limitation is real: it does not block DHT. But the solution the video points to, an unproven branded peptide product, has no clinical trial support for filling that gap.
- The phrase 'reversal of hair loss at the cellular level' is marketing language, not a clinical claim supported by any published human study on EFX Regen or equivalent products.
- Anyone experiencing hair loss should have the underlying cause evaluated by a licensed clinician before starting any supplement, peptide or otherwise, because the treatment approach differs significantly depending on whether the cause is hormonal, inflammatory, nutritional, or structural.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Hair Rescue · TikTok creator
191.3K views on this video
Try EFX Regen today! #hair #fyp #viralvideo #hairgrowthpeptides
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Hair Rescue, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.